Concepedia

Sergey Cheporov

SC

Statistics

Publications

7

Citations

1.1K

H-Index

7

Active since

2007

Affiliations

Northwestern University(Current)

City Clinical Oncology Center

Leningrad Regional Cancer Center

Sergey Cheporov is an author at Northwestern University specializing in medicine, chemotherapy, and oncology.

Publications per year

2007–2022

7

Publications

7

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer

Ying Cheng, Liang Han, Lin Wu et al. · JAMA · 2022 · 456 citations · Full text

Medicine, Oncology, Pharmacology +17

Significantly Longer Progression-Free Survival With <i>nab</i>-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast Cancer

William J. Gradishar, D. Krasnojon, Sergey Cheporov et al. · Journal of Clinical Oncology · 2009 · 343 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase II Trial of Nab-Paclitaxel Compared With Docetaxel as First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Final Analysis of Overall Survival

William J. Gradishar, D. Krasnojon, Sergey Cheporov et al. · Clinical Breast Cancer · 2012 · 122 citations

Medicine, Oncology, Pharmacology +11

Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial

Josep Tabernero, Rocio García‐Carbonero, James T. Cassidy et al. · Clinical Cancer Research · 2013 · 90 citations

Medicine, Oncology, Pharmacotherapy +12

A Dose Finding Study of Weekly and Every-3-Week nab-Paclitaxel Followed by Carboplatin as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer

Mark A. Socinski, G. Manikhas, Daniil Stroyakovsky et al. · Journal of Thoracic Oncology · 2010 · 77 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 7